Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-047538
Filing Date
2011-05-09
Accepted
2011-05-09 17:25:22
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b85482e10vq.htm 10-Q 637295
2 EX-31.1 b85482exv31w1.htm EX-31.1 6129
3 EX-31.2 b85482exv31w2.htm EX-31.2 6105
4 EX-32.1 b85482exv32w1.htm EX-32.1 4721
10 GRAPHIC b85482b8548200.gif GRAPHIC 2525
  Complete submission text file 0000950123-11-047538.txt   4149610

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT alr-20110331.xml EX-101.INS 748093
6 EX-101 SCHEMA DOCUMENT alr-20110331.xsd EX-101.SCH 16902
7 EX-101 CALCULATION LINKBASE DOCUMENT alr-20110331_cal.xml EX-101.CAL 65693
8 EX-101 LABELS LINKBASE DOCUMENT alr-20110331_lab.xml EX-101.LAB 200493
9 EX-101 PRESENTATION LINKBASE DOCUMENT alr-20110331_pre.xml EX-101.PRE 111215
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
ALERE INC. (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16789 | Film No.: 11824613
SIC: 2835 In Vitro & In Vivo Diagnostic Substances